Related Experiment Video
Updated: Mar 27, 2026

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
Immunosuppression in IgA nephropathy: how certain are we?
1Division of Nephrology and Clinical Immunology, RWTH University of Aachen, Aachen, Germany.
For IgA nephropathy, the best treatment is debated. A new trial shows comprehensive supportive care is better than immunosuppressive therapy for high-risk patients.
Area of Science:
- Nephrology
- Immunology
- Clinical Trials
Background:
- Immunosuppressive therapy's role in IgA nephropathy treatment remains uncertain.
- Identifying optimal treatment strategies for IgA nephropathy is crucial for preventing disease progression.
Purpose of the Study:
- To evaluate the efficacy of immunosuppressive therapy versus comprehensive supportive care in IgA nephropathy patients at high risk for progression.
Main Methods:
- A randomized controlled trial was conducted.
- Patients were stratified based on risk for disease progression.
Main Results:
- The trial results strongly support comprehensive supportive care.
- Comprehensive supportive care demonstrated superior outcomes compared to immunosuppressive therapy in high-risk IgA nephropathy patients.
Conclusions:
- Comprehensive supportive care should be prioritized over immunosuppressive therapy for high-risk IgA nephropathy patients.
- Further research may refine treatment protocols for IgA nephropathy.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Nephrotic Syndrome I : Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant III: Nursing Management
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Kidney Transplant II: Surgical Procedure

